Trxade Group Inc (MEDS) — Cash Flow Reinvestment Rate
Trxade Group Inc (MEDS) has a Cash Flow Reinvestment Rate of 0.00x as of June 2024, reinvesting $774.00 (capex $0.00 plus investments $-774.00) from operating cash flow of $4.22 Million. See financial flexibility index of Trxade Group Inc to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Trxade Group Inc Cash Flow Reinvestment Rate (2017–2019)
Historical reinvestment intensity for Trxade Group Inc across 3 annual periods. Explore MEDS operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Trxade Group Inc (2017–2019)
Year-by-year capital reinvestment analysis for Trxade Group Inc. For the full cash flow conversion analysis, see cash flow conversion of Trxade Group Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 2.92x | $414.50K | $141.78K | $82.25K | ▲ +185.2% |
| 2018 | 1.03x | $280.29K | $273.39K | $15.01K | ▼ -33.6% |
| 2017 | 1.54x | $265.01K | $171.67K | $15.01K | — |